In a filing, Hologic, Inc revealed its Director Stamoulis Christiana unloaded Company’s shares for reported $0.54 million on Oct 20 ’25. In the deal valued at $73.07 per share,7,402 shares were sold. As a result of this transaction, Stamoulis Christiana now holds 47,336 shares worth roughly $3.54 million.
Then, Stamoulis Christiana bought 7,402 shares, generating $540,864 in total proceeds.
Before that, MACMILLAN STEPHEN P sold 138,358 shares. Hologic, Inc shares valued at $9,266,118 were divested by the Chairman, President and CEO at a price of $66.97 per share. As a result of the transaction, MACMILLAN STEPHEN P now holds 1,234,624 shares, worth roughly $92.44 million.
Argus downgraded its Hologic, Inc [HOLX] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who decreased its forecast for the stock in early January from “an Outperform” to “an In-line”. BNP Paribas Exane also remained covering HOLX and has decreased its forecast on November 21, 2025 with a “Neutral” recommendation from previously “an Outperform” rating. Evercore ISI revised its rating on October 07, 2025. It rated HOLX as “an Outperform” which previously was an “an In-line”.
Price Performance Review of HOLX
On Tuesday, Hologic, Inc [NASDAQ:HOLX] saw its stock jump 0.01% to $74.87. Over the last five days, the stock has lost -0.05%. Hologic, Inc shares have risen nearly 4.42% since the year began. Nevertheless, the stocks have risen 0.51% over the past one year.
How much short interest is there in Hologic, Inc?
A steep rise in short interest was recorded in Hologic, Inc stocks on 2025-12-31, dropping by -0.57 million shares to a total of 3.75 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 4.32 million shares. There was a decline of -15.22%, which implies that there is a negative sentiment for the stock.
